Anika Therapeutics: Barrington Research raises PT to $16, maintains Outperform rating.

jueves, 6 de noviembre de 2025, 3:31 pm ET1 min de lectura
ANIK--

Anika Therapeutics: Barrington Research raises PT to $16, maintains Outperform rating.

Anika Therapeutics: Barrington Research raises PT to $16, maintains Outperform rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios